Page 53 - Micron News Today

COVID-19 vaccines are effective against severe cases of the disease in children and adolescents, according to a review.

Findings from a two-year study of nearly 2,400 solid organ transplant recipients, conducted by the Johns Hopkins Transplant Research Center (TRC) in collaboration with the New York University Center for Surgical and Applied Transplant Research, indicate spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus' omicron subvariant.

Micron: The memory chipmaker said it has submitted applications to the U.S. Department of Commerce for funding under the CHIPS Act, aimed at boosting efforts to diversify supply chains to be less reliant on China.

With an updated booster still weeks or months away, is the currently available vaccine effective against the COVID strains circulating now?

Dubbed "Pirola" by variant trackers, the strain is different enough from other Omicron to potentially warrant a Greek letter from the WHO, experts say.

After recently overtaking China as the world’s most populous country, India poses the strongest macroeconomic promise for massive scale and development

COVID-19 vaccine in organ transplant recipients has proven to reduce hospital stay mitigating the risk of long-term complications

The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants on host viral burden.

Mobs of Muslims attacked some 21 churches and dozens of Christian homes after two Christians were accused of committing blasphemy by desecrating the Quran in

The World Health Organization added a new lineage of the SARS-CoV-2 virus to its Variants Under Monitoring (VUM) category on Thursday, citing a large number of mutations that “warrants attention.”